Pediatrix Medical Group Hits Day High with 24.22% Surge in Stock Price

Pediatrix Medical Group, Inc. has experienced significant activity today, achieving a remarkable gain of 24.22% as of November 3, 2025. The stock reached an intraday high of USD 21.24, reflecting strong performance metrics that distinguish it within the Pharmaceuticals & Biotechnology sector.
Over the past year, Pediatrix has generated a return of 56.82%, significantly outperforming the S&P 500, which recorded a return of 16.64%. The company's market capitalization stands at USD 1,476 million, classifying it as a small-cap stock. Key financial indicators reveal a price-to-earnings (P/E) ratio of 8.00 and a return on equity of 18.01%, suggesting efficient management of shareholder equity.

Pediatrix's operating cash flow reached a peak of USD 244.56 million, while its return on capital employed (ROCE) was reported at 16.57%. The company maintains a strong interest coverage ratio of 755.9, indicating robust financial health. With institutional holdings at 100%, Pediatrix Medical Group, Inc. continues to demonstrate a solid market position and performance, making it a noteworthy player in its industry.